Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA rejection
Biotech
Lykos caps off chaotic week by cutting 75% of staff
Lykos Therapeutics is laying off about 75% of its staff in the aftermath of an FDA rejection and the retraction of three MDMA research papers.
Darren Incorvaia
Aug 15, 2024 3:59pm
Lykos' MDMA treatment for PTSD has been quashed at the FDA
Aug 10, 2024 9:07am
Minerva's schizophrenia drug rejected by FDA for 2nd time
Feb 27, 2024 9:34am
With FDA rejection for eye drug, Aldeyra plans speedy new trial
Nov 28, 2023 4:30am
FDA reverses rejection of Vivos mouthpiece for sleep apnea
Jan 4, 2023 11:12am
BrainStorm shares tumble as FDA again knocks back ALS drug
Nov 10, 2022 10:05am